Within-subject variability in cocaine pharmacokinetics and pharmacodynamics after intraperitoneal compared with intravenous cocaine administration

Experimental and Clinical Psychopharmacology

Volumn 7, Issue 1, 1999, Pages 3-12

  Ma, Fang ^a,b   Falk, John L ^a,b,c   Lau, Chyan E ^a,b  

^a Rutgers University   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; COCAINE; NORCOCAINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PSYCHOPHARMACOLOGY; RAT; REINFORCEMENT; REPRODUCIBILITY;

ANIMALS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 0032972687     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.7.1.3     Document Type: Article

References (41)

1. Barnett, G., Hawks, R., & Resnick, R. (1981). Cocaine pharmacokinetics in humans. Journal of Ethnophannacology, 3, 353-366.
2. Benuck, M., Lajtha, A., & Reith, M. E. A. (1987). Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. Journal of Pharmacology and Experimental Therapeutics, 243, 144-149.
3. Boni, J. P., Barr, W. H., & Martin, B. R. (1991). Cocaine inhalation in the rat: Pharmacokinetics and cardiovascular response. Journal of Pharmacology and Experimental Therapeutics, 257, 307-315.
4. Booze, R. M., Lehner, A. F., Wallace, D. R., Welch, M. A., & Mactutus, C. F. (1997). Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats. Neurotoxicology Teratology, 19, 7-15.
5. Bruckner, J. V., Jiang, W. D., Ho, B. T., & Levy, B. M. (1982). Histopathological evaluation of cocaine-induced skin lesions in the rat. Journal of Cutaneous Pathology, 9, 83-95.
6. Cone, E. J., Kumor, K., Thompson, L. K., & Sherer, M. (1988). Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. Journal of Analytical Toxicology, 12, 200-206.
7. Dingemanse, J., Danhof, M., & Breimer, D. D. (1988). Pharmacokinetic-pharmacodynamic modeling of CNS drug effects. An overview. Pharmacology and Therapeutics, 38, 1-52.
8. Dow-Edwards, D., Fico, T. A., Osman, M., Gamagaris, Z., & Hutchings, D. E. (1989). Comparison of oral and subcutaneous routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats. Pharmacology Biochemistry and Behavior, 33, 167-173.
9. Durazzo, T. C., Gauvin, D. V., Goulden, K. L., Briscoe, R. J., & Holloway, F. A. (1994). Technical report: The subcutaneous administration of cocaine in the rat. Pharmacology Biochemistry and Behavior, 49, 1007-1010.
10. Emmett-Oglesby, M. W. (1995). Sensitization and tolerance to the motivational and subjective effects of psychomotor stimulant. In R. P. Hammer, Jr. (Ed.), The neurobiology of cocaine (pp. 31-47). New York: CRC Press.
11. Evans, S. M., Cone, E. J., & Henningfield, J. E. (1996). Arterial and venous cocaine plasma concentrations in humans: Relationship to route of administration, cardiovascular effects and subjective effects. Journal of Pharmacology and Experimental Therapeutics, 279, 1345-1356.
12. Falk, J. L., Ma, F., & Lau, C. E. (1991). Chronic oral cocaine self-administration: Pharmacokinetics and effects on spontaneous and discriminative motor functions. Journal of Pharmacology and Experimental Therapeutics, 257, 457-465.
13. Farre, M., Torre, R. D., Llorente, M., Lamas, X., Ugena, B., Segura, J., & Cami, J. (1993). Alcohol and cocaine interactions in humans. Journal of Pharmacology and Experimental Therapeutics, 266, 1364-1373.
14. Foltin, R. W., & Fischman, M. W. (1991). Smoked and intravenous cocaine in humans: Acute tolerance, cardiovascular and subjective effects. Journal of Pharmacology and Experimental Therapeutics, 257, 247-261.
15. Inaba, T. (1989). Cocaine: Pharmacokinetics and biotransformation in man. Canadian Journal of Physiology and Pharmacology, 67, 1154-1157.
16. Jandel Scientific Software. (1995). SigmaStat [Computer software]. San Rafael, CA: Authors.
17. Javaid, J. I., Fischman, M. W., Schuster, C. R., Dekirmenjian, H., & Davis, J. M. (1978, October 13). Cocaine plasma concentration: Relation to physiological and subjective effects in humans. Science, 202, 227-228.
18. Jeffcoat, A. R., Perez-Reyes, M., Hill, J. M., Sadler, B. M., & Cook, C. E. (1989). Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 17, 153-159.
19. Johanson, C., & Fischman, M. W. (1989). The pharmacology of cocaine related to its abuse. Pharmacological Reviews, 41, 3-52.
20. Lamas, X., Negus, S. S., Hall, E., & Mello, N. K. (1995). Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys. Psychopharmacology, 121, 331-338.
21. Lau, C. E., & Falk, J. F. (1991). [Lack of effect after IP cocaine or pentobarbital administration]. Unpublished raw data.
22. Lau, C. E., & Heatherington, A. C. (1997). Pharmacokinetic-pharmacodynamic modeling of stimulatory and sedative effects of alprazolam: Timing performance deficits. Journal of Pharmacology and Experimental Therapeutics, 283, 1119-1129.
23. Lau, C. E., Imam, A., Ma, F., & Falk, J. L. (1991). Acute effects of cocaine on spontaneous discriminative motor functions: Relation to route of administration and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics, 257, 444-456.
24. Lau, C. E., Ma, F., & Falk, J. L. (in press). Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: Timing performance deficits. Journal of Pharmacology and Experimental Therapeutics.
25. Lau, C. E., Ma, F., & Falk, J. L. (1990). Simultaneous determination of cocaine and its metabolites with caffeine in rat serum microsamples by high performance liquid chromatography. Journal of Chromatography, 532, 95-103.
26. Lau, C. E., Ma, F., Wang, Y., & Falk, J. L. (1998). How dependable is the IP route? Pharmacokinetic and pharmacodynamic evidence for cocaine and midazolam (NIDA Research Monograph 178:219). In Problems of Drug Dependence 1997: Proceedings of the 59th Annual Scientific Meeting of the College on Problems of Drug Dependence (NIH Publication No. 98-4305). Washington, DC: U.S. Government Printing Office.
27. Lau, C. E., Ma, F., Wang, Y., & Smith, C. (1996). Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: Relating DRL performance to pharmacokinetics. Psychopharmacology, 126, 241-248.
28. Lau, C. E., & Wang, J. (1996). Alprazolam, caffeine and their interaction: Relating DRL performance to pharmacokinetics. Psychopharmacology, 126, 115-124.
29. Lau, C. E., Wang, Y., & Falk, J. L. (1997). Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: Independent interaction of alprazolam and caffeine. Journal of Pharmacology and Experimental Therapeutics, 281, 1013-1029.
30. Lau, C. E., Wang, Y., & Ma, F. (1998). Pharmacokinetic-pharmacodynamic modeling of the coexistence of stimulatory and sedative components for midazolam. European Journal of Pharmacology, 346, 131-144.
31. Laurijssens, B. E., & Greenblatt, D. J. (1996). Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clinical Pharmacokinetics, 30, 52-76.
32. Ma, F., Zhang, J., & Lau, C. E. (1997). Determination of cocaine and its metabolites in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats. Journal of Chromatography B: Biomedical Applications, 693, 307-312.
33. National Institutes of Health. (1985). Guide for the care and use of laboratory animals (NIH Publication No. 85-23, revised). Bethesda, MD: Author.
34. 3H]cocaine in acutely and chronically treated rats. Journal of Pharmacology and Experimental Therapeutics, 196, 556-569.
35. Orona, R. A., Mayfield, R. D., Cline, E. J., & Zahniser, N. R. (1994). Repeated intravenous cocaine administration to rats produces behavioral sensitization without changing brain cocaine levels. Neuroscience Letters, 167, 121-124.
36. Pan, H., Menacherry, S., & Justice, J. B., Jr. (1991). Differences in the pharmacokinetics in naïve and cocaine-experienced rats. Journal of Neurochemistry, 56, 1299-1306.
37. SAAM Institute. (1997). SAAM II User Guide. (Available from the SAAM Institute, Fl-20, University of Washington, Seattle, WA 98195).
38. Scheel-Kruger, J., Braestrup, C., Nielson, M., Golembioska, K., & Mogilnicka, E. (1977). Cocaine: Discussion on the role of dopamine in the biochemical mechanisms of action. In E. K. Ellinwood and M. M. Kilbey (Eds.), Cocaine and other stimulants (pp. 373-407). New York: Plenum.
39. Wang, Y., & Lau, C. E. (1998). Caffeine has similar pharmacokinetics and behavioral effects via the IP and PO routes of administration. Pharmacology Biochemistry and Behavior, 60, 271-278.
40. Wilkinson, P., Van Dyke, C., Jatlow, P., Barash, P., & Byck, R. (1980). Intranasal and oral cocaine kinetics. Clinical Pharmacology and Therapeutics, 27, 386-394.
41. Woolverton, W. L., & Balster, R. L. (1982). Behavioral pharmacology of local anesthetics: Reinforcing and discriminative stimulus effects. Pharmacology Biochemistry and Behavior, 16, 491-500.